 | • レポートコード：QYR2104Z5968 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、154ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、ボリコナゾール（Vfend）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（注射、錠剤、カプセル）、用途別市場規模（人用、動物用）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ボリコナゾール（Vfend）の市場動向 ・企業の競争状況、市場シェア ・ボリコナゾール（Vfend）の種類別市場規模（注射、錠剤、カプセル） ・ボリコナゾール（Vfend）の用途別市場規模（人用、動物用） ・ボリコナゾール（Vfend）の北米市場規模2016-2027（アメリカ、カナダ） ・ボリコナゾール（Vfend）のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ボリコナゾール（Vfend）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ボリコナゾール（Vfend）の中南米市場規模2016-2027（メキシコ、ブラジル） ・ボリコナゾール（Vfend）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Apotex、Accord Healthcare、Mylan Pharmaceuticals、Pharmascience (Joddes)、Auro Pharma、Roche、Macherey-Nagel GmbH、Jincheng HEALTH Pharmaceutical、Takeda、Novartis、Aditya Pharma、Daiichi Sankyo、Taj Pharmaceuticals、Sandoz、Ebang Pharmaceutical、GSK、Teva、Cilag AG、Squibb、Abbott、Livzon Pharmaceutical Group、Sichuan Beauty Sport Huakang Pharmaceutical、Jincheng Haisi Pharmaceutical、Zhuhai Yibang Pharmaceutical、Beijing Bokang Gene Technology、Chengdu Taihe Health Technology Group、Yangtze Pharmaceutical Group、Hubei Wushi Pharmaceutical） ・結論 |
Voriconazole is a broad-spectrum antifungal agent for fungal infections in humans and animals.
Market Analysis and Insights: Global Voriconazole Vfend Market
The global Voriconazole Vfend market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Voriconazole Vfend market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Voriconazole Vfend market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Voriconazole Vfend market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Voriconazole Vfend market.
Global Voriconazole Vfend Scope and Market Size
Voriconazole Vfend market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Voriconazole Vfend market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Injection
Tablets
Capsule
Segment by Application
For People
For Animal
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pfizer
Apotex
Accord Healthcare
Mylan Pharmaceuticals
Pharmascience (Joddes)
Auro Pharma
Roche
Macherey-Nagel GmbH
Jincheng HEALTH Pharmaceutical
Takeda
Novartis
Aditya Pharma
Daiichi Sankyo
Taj Pharmaceuticals
Sandoz
Ebang Pharmaceutical
GSK
Teva
Cilag AG
Squibb
Abbott
Livzon Pharmaceutical Group
Sichuan Beauty Sport Huakang Pharmaceutical
Jincheng Haisi Pharmaceutical
Zhuhai Yibang Pharmaceutical
Beijing Bokang Gene Technology
Chengdu Taihe Health Technology Group
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Voriconazole Vfend Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Injection
1.2.3 Tablets
1.2.4 Capsule
1.3 Market by Application
1.3.1 Global Voriconazole Vfend Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 For People
1.3.3 For Animal
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Voriconazole Vfend Market Perspective (2016-2027)
2.2 Voriconazole Vfend Growth Trends by Regions
2.2.1 Voriconazole Vfend Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Voriconazole Vfend Historic Market Share by Regions (2016-2021)
2.2.3 Voriconazole Vfend Forecasted Market Size by Regions (2022-2027)
2.3 Voriconazole Vfend Industry Dynamic
2.3.1 Voriconazole Vfend Market Trends
2.3.2 Voriconazole Vfend Market Drivers
2.3.3 Voriconazole Vfend Market Challenges
2.3.4 Voriconazole Vfend Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Voriconazole Vfend Players by Revenue
3.1.1 Global Top Voriconazole Vfend Players by Revenue (2016-2021)
3.1.2 Global Voriconazole Vfend Revenue Market Share by Players (2016-2021)
3.2 Global Voriconazole Vfend Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Voriconazole Vfend Revenue
3.4 Global Voriconazole Vfend Market Concentration Ratio
3.4.1 Global Voriconazole Vfend Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Voriconazole Vfend Revenue in 2020
3.5 Voriconazole Vfend Key Players Head office and Area Served
3.6 Key Players Voriconazole Vfend Product Solution and Service
3.7 Date of Enter into Voriconazole Vfend Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Voriconazole Vfend Breakdown Data by Type
4.1 Global Voriconazole Vfend Historic Market Size by Type (2016-2021)
4.2 Global Voriconazole Vfend Forecasted Market Size by Type (2022-2027)
5 Voriconazole Vfend Breakdown Data by Application
5.1 Global Voriconazole Vfend Historic Market Size by Application (2016-2021)
5.2 Global Voriconazole Vfend Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Voriconazole Vfend Market Size (2016-2027)
6.2 North America Voriconazole Vfend Market Size by Type
6.2.1 North America Voriconazole Vfend Market Size by Type (2016-2021)
6.2.2 North America Voriconazole Vfend Market Size by Type (2022-2027)
6.2.3 North America Voriconazole Vfend Market Size by Type (2016-2027)
6.3 North America Voriconazole Vfend Market Size by Application
6.3.1 North America Voriconazole Vfend Market Size by Application (2016-2021)
6.3.2 North America Voriconazole Vfend Market Size by Application (2022-2027)
6.3.3 North America Voriconazole Vfend Market Size by Application (2016-2027)
6.4 North America Voriconazole Vfend Market Size by Country
6.4.1 North America Voriconazole Vfend Market Size by Country (2016-2021)
6.4.2 North America Voriconazole Vfend Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Voriconazole Vfend Market Size (2016-2027)
7.2 Europe Voriconazole Vfend Market Size by Type
7.2.1 Europe Voriconazole Vfend Market Size by Type (2016-2021)
7.2.2 Europe Voriconazole Vfend Market Size by Type (2022-2027)
7.2.3 Europe Voriconazole Vfend Market Size by Type (2016-2027)
7.3 Europe Voriconazole Vfend Market Size by Application
7.3.1 Europe Voriconazole Vfend Market Size by Application (2016-2021)
7.3.2 Europe Voriconazole Vfend Market Size by Application (2022-2027)
7.3.3 Europe Voriconazole Vfend Market Size by Application (2016-2027)
7.4 Europe Voriconazole Vfend Market Size by Country
7.4.1 Europe Voriconazole Vfend Market Size by Country (2016-2021)
7.4.2 Europe Voriconazole Vfend Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Voriconazole Vfend Market Size (2016-2027)
8.2 Asia-Pacific Voriconazole Vfend Market Size by Type
8.2.1 Asia-Pacific Voriconazole Vfend Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Voriconazole Vfend Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Voriconazole Vfend Market Size by Type (2016-2027)
8.3 Asia-Pacific Voriconazole Vfend Market Size by Application
8.3.1 Asia-Pacific Voriconazole Vfend Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Voriconazole Vfend Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Voriconazole Vfend Market Size by Application (2016-2027)
8.4 Asia-Pacific Voriconazole Vfend Market Size by Region
8.4.1 Asia-Pacific Voriconazole Vfend Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Voriconazole Vfend Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Voriconazole Vfend Market Size (2016-2027)
9.2 Latin America Voriconazole Vfend Market Size by Type
9.2.1 Latin America Voriconazole Vfend Market Size by Type (2016-2021)
9.2.2 Latin America Voriconazole Vfend Market Size by Type (2022-2027)
9.2.3 Latin America Voriconazole Vfend Market Size by Type (2016-2027)
9.3 Latin America Voriconazole Vfend Market Size by Application
9.3.1 Latin America Voriconazole Vfend Market Size by Application (2016-2021)
9.3.2 Latin America Voriconazole Vfend Market Size by Application (2022-2027)
9.3.3 Latin America Voriconazole Vfend Market Size by Application (2016-2027)
9.4 Latin America Voriconazole Vfend Market Size by Country
9.4.1 Latin America Voriconazole Vfend Market Size by Country (2016-2021)
9.4.2 Latin America Voriconazole Vfend Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Voriconazole Vfend Market Size (2016-2027)
10.2 Middle East & Africa Voriconazole Vfend Market Size by Type
10.2.1 Middle East & Africa Voriconazole Vfend Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Voriconazole Vfend Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Voriconazole Vfend Market Size by Type (2016-2027)
10.3 Middle East & Africa Voriconazole Vfend Market Size by Application
10.3.1 Middle East & Africa Voriconazole Vfend Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Voriconazole Vfend Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Voriconazole Vfend Market Size by Application (2016-2027)
10.4 Middle East & Africa Voriconazole Vfend Market Size by Country
10.4.1 Middle East & Africa Voriconazole Vfend Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Voriconazole Vfend Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Voriconazole Vfend Introduction
11.1.4 Pfizer Revenue in Voriconazole Vfend Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Apotex
11.2.1 Apotex Company Details
11.2.2 Apotex Business Overview
11.2.3 Apotex Voriconazole Vfend Introduction
11.2.4 Apotex Revenue in Voriconazole Vfend Business (2016-2021)
11.2.5 Apotex Recent Development
11.3 Accord Healthcare
11.3.1 Accord Healthcare Company Details
11.3.2 Accord Healthcare Business Overview
11.3.3 Accord Healthcare Voriconazole Vfend Introduction
11.3.4 Accord Healthcare Revenue in Voriconazole Vfend Business (2016-2021)
11.3.5 Accord Healthcare Recent Development
11.4 Mylan Pharmaceuticals
11.4.1 Mylan Pharmaceuticals Company Details
11.4.2 Mylan Pharmaceuticals Business Overview
11.4.3 Mylan Pharmaceuticals Voriconazole Vfend Introduction
11.4.4 Mylan Pharmaceuticals Revenue in Voriconazole Vfend Business (2016-2021)
11.4.5 Mylan Pharmaceuticals Recent Development
11.5 Pharmascience (Joddes)
11.5.1 Pharmascience (Joddes) Company Details
11.5.2 Pharmascience (Joddes) Business Overview
11.5.3 Pharmascience (Joddes) Voriconazole Vfend Introduction
11.5.4 Pharmascience (Joddes) Revenue in Voriconazole Vfend Business (2016-2021)
11.5.5 Pharmascience (Joddes) Recent Development
11.6 Auro Pharma
11.6.1 Auro Pharma Company Details
11.6.2 Auro Pharma Business Overview
11.6.3 Auro Pharma Voriconazole Vfend Introduction
11.6.4 Auro Pharma Revenue in Voriconazole Vfend Business (2016-2021)
11.6.5 Auro Pharma Recent Development
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Roche Business Overview
11.7.3 Roche Voriconazole Vfend Introduction
11.7.4 Roche Revenue in Voriconazole Vfend Business (2016-2021)
11.7.5 Roche Recent Development
11.8 Macherey-Nagel GmbH
11.8.1 Macherey-Nagel GmbH Company Details
11.8.2 Macherey-Nagel GmbH Business Overview
11.8.3 Macherey-Nagel GmbH Voriconazole Vfend Introduction
11.8.4 Macherey-Nagel GmbH Revenue in Voriconazole Vfend Business (2016-2021)
11.8.5 Macherey-Nagel GmbH Recent Development
11.9 Jincheng HEALTH Pharmaceutical
11.9.1 Jincheng HEALTH Pharmaceutical Company Details
11.9.2 Jincheng HEALTH Pharmaceutical Business Overview
11.9.3 Jincheng HEALTH Pharmaceutical Voriconazole Vfend Introduction
11.9.4 Jincheng HEALTH Pharmaceutical Revenue in Voriconazole Vfend Business (2016-2021)
11.9.5 Jincheng HEALTH Pharmaceutical Recent Development
11.10 Takeda
11.10.1 Takeda Company Details
11.10.2 Takeda Business Overview
11.10.3 Takeda Voriconazole Vfend Introduction
11.10.4 Takeda Revenue in Voriconazole Vfend Business (2016-2021)
11.10.5 Takeda Recent Development
11.11 Novartis
11.11.1 Novartis Company Details
11.11.2 Novartis Business Overview
11.11.3 Novartis Voriconazole Vfend Introduction
11.11.4 Novartis Revenue in Voriconazole Vfend Business (2016-2021)
11.11.5 Novartis Recent Development
11.12 Aditya Pharma
11.12.1 Aditya Pharma Company Details
11.12.2 Aditya Pharma Business Overview
11.12.3 Aditya Pharma Voriconazole Vfend Introduction
11.12.4 Aditya Pharma Revenue in Voriconazole Vfend Business (2016-2021)
11.12.5 Aditya Pharma Recent Development
11.13 Daiichi Sankyo
11.13.1 Daiichi Sankyo Company Details
11.13.2 Daiichi Sankyo Business Overview
11.13.3 Daiichi Sankyo Voriconazole Vfend Introduction
11.13.4 Daiichi Sankyo Revenue in Voriconazole Vfend Business (2016-2021)
11.13.5 Daiichi Sankyo Recent Development
11.14 Taj Pharmaceuticals
11.14.1 Taj Pharmaceuticals Company Details
11.14.2 Taj Pharmaceuticals Business Overview
11.14.3 Taj Pharmaceuticals Voriconazole Vfend Introduction
11.14.4 Taj Pharmaceuticals Revenue in Voriconazole Vfend Business (2016-2021)
11.14.5 Taj Pharmaceuticals Recent Development
11.15 Sandoz
11.15.1 Sandoz Company Details
11.15.2 Sandoz Business Overview
11.15.3 Sandoz Voriconazole Vfend Introduction
11.15.4 Sandoz Revenue in Voriconazole Vfend Business (2016-2021)
11.15.5 Sandoz Recent Development
11.16 Ebang Pharmaceutical
11.16.1 Ebang Pharmaceutical Company Details
11.16.2 Ebang Pharmaceutical Business Overview
11.16.3 Ebang Pharmaceutical Voriconazole Vfend Introduction
11.16.4 Ebang Pharmaceutical Revenue in Voriconazole Vfend Business (2016-2021)
11.16.5 Ebang Pharmaceutical Recent Development
11.17 GSK
11.17.1 GSK Company Details
11.17.2 GSK Business Overview
11.17.3 GSK Voriconazole Vfend Introduction
11.17.4 GSK Revenue in Voriconazole Vfend Business (2016-2021)
11.17.5 GSK Recent Development
11.18 Teva
11.18.1 Teva Company Details
11.18.2 Teva Business Overview
11.18.3 Teva Voriconazole Vfend Introduction
11.18.4 Teva Revenue in Voriconazole Vfend Business (2016-2021)
11.18.5 Teva Recent Development
11.18 Cilag AG
11.25.1 Cilag AG Company Details
11.25.2 Cilag AG Business Overview
11.25.3 Cilag AG Voriconazole Vfend Introduction
11.25.4 Cilag AG Revenue in Voriconazole Vfend Business (2016-2021)
11.25.5 Cilag AG Recent Development
11.20 Squibb
11.20.1 Squibb Company Details
11.20.2 Squibb Business Overview
11.20.3 Squibb Voriconazole Vfend Introduction
11.20.4 Squibb Revenue in Voriconazole Vfend Business (2016-2021)
11.20.5 Squibb Recent Development
11.21 Abbott
11.21.1 Abbott Company Details
11.21.2 Abbott Business Overview
11.21.3 Abbott Voriconazole Vfend Introduction
11.21.4 Abbott Revenue in Voriconazole Vfend Business (2016-2021)
11.21.5 Abbott Recent Development
11.22 Livzon Pharmaceutical Group
11.22.1 Livzon Pharmaceutical Group Company Details
11.22.2 Livzon Pharmaceutical Group Business Overview
11.22.3 Livzon Pharmaceutical Group Voriconazole Vfend Introduction
11.22.4 Livzon Pharmaceutical Group Revenue in Voriconazole Vfend Business (2016-2021)
11.22.5 Livzon Pharmaceutical Group Recent Development
11.23 Sichuan Beauty Sport Huakang Pharmaceutical
11.23.1 Sichuan Beauty Sport Huakang Pharmaceutical Company Details
11.23.2 Sichuan Beauty Sport Huakang Pharmaceutical Business Overview
11.23.3 Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Vfend Introduction
11.23.4 Sichuan Beauty Sport Huakang Pharmaceutical Revenue in Voriconazole Vfend Business (2016-2021)
11.23.5 Sichuan Beauty Sport Huakang Pharmaceutical Recent Development
11.24 Jincheng Haisi Pharmaceutical
11.24.1 Jincheng Haisi Pharmaceutical Company Details
11.24.2 Jincheng Haisi Pharmaceutical Business Overview
11.24.3 Jincheng Haisi Pharmaceutical Voriconazole Vfend Introduction
11.24.4 Jincheng Haisi Pharmaceutical Revenue in Voriconazole Vfend Business (2016-2021)
11.24.5 Jincheng Haisi Pharmaceutical Recent Development
11.25 Zhuhai Yibang Pharmaceutical
11.25.1 Zhuhai Yibang Pharmaceutical Company Details
11.25.2 Zhuhai Yibang Pharmaceutical Business Overview
11.25.3 Zhuhai Yibang Pharmaceutical Voriconazole Vfend Introduction
11.25.4 Zhuhai Yibang Pharmaceutical Revenue in Voriconazole Vfend Business (2016-2021)
11.25.5 Zhuhai Yibang Pharmaceutical Recent Development
11.26 Beijing Bokang Gene Technology
11.26.1 Beijing Bokang Gene Technology Company Details
11.26.2 Beijing Bokang Gene Technology Business Overview
11.26.3 Beijing Bokang Gene Technology Voriconazole Vfend Introduction
11.26.4 Beijing Bokang Gene Technology Revenue in Voriconazole Vfend Business (2016-2021)
11.26.5 Beijing Bokang Gene Technology Recent Development
11.27 Chengdu Taihe Health Technology Group
11.27.1 Chengdu Taihe Health Technology Group Company Details
11.27.2 Chengdu Taihe Health Technology Group Business Overview
11.27.3 Chengdu Taihe Health Technology Group Voriconazole Vfend Introduction
11.27.4 Chengdu Taihe Health Technology Group Revenue in Voriconazole Vfend Business (2016-2021)
11.27.5 Chengdu Taihe Health Technology Group Recent Development
11.28 Yangtze Pharmaceutical Group
11.28.1 Yangtze Pharmaceutical Group Company Details
11.28.2 Yangtze Pharmaceutical Group Business Overview
11.28.3 Yangtze Pharmaceutical Group Voriconazole Vfend Introduction
11.28.4 Yangtze Pharmaceutical Group Revenue in Voriconazole Vfend Business (2016-2021)
11.28.5 Yangtze Pharmaceutical Group Recent Development
11.29 Hubei Wushi Pharmaceutical
11.29.1 Hubei Wushi Pharmaceutical Company Details
11.29.2 Hubei Wushi Pharmaceutical Business Overview
11.29.3 Hubei Wushi Pharmaceutical Voriconazole Vfend Introduction
11.29.4 Hubei Wushi Pharmaceutical Revenue in Voriconazole Vfend Business (2016-2021)
11.29.5 Hubei Wushi Pharmaceutical Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Voriconazole Vfend Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Injection
Table 3. Key Players of Tablets
Table 4. Key Players of Capsule
Table 5. Global Voriconazole Vfend Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Voriconazole Vfend Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Voriconazole Vfend Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Voriconazole Vfend Market Share by Regions (2016-2021)
Table 9. Global Voriconazole Vfend Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Voriconazole Vfend Market Share by Regions (2022-2027)
Table 11. Voriconazole Vfend Market Trends
Table 12. Voriconazole Vfend Market Drivers
Table 13. Voriconazole Vfend Market Challenges
Table 14. Voriconazole Vfend Market Restraints
Table 15. Global Voriconazole Vfend Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Voriconazole Vfend Market Share by Players (2016-2021)
Table 17. Global Top Voriconazole Vfend Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Voriconazole Vfend as of 2020)
Table 18. Ranking of Global Top Voriconazole Vfend Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Voriconazole Vfend Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Voriconazole Vfend Product Solution and Service
Table 22. Date of Enter into Voriconazole Vfend Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Voriconazole Vfend Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Voriconazole Vfend Revenue Market Share by Type (2016-2021)
Table 26. Global Voriconazole Vfend Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Voriconazole Vfend Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Voriconazole Vfend Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Voriconazole Vfend Revenue Market Share by Application (2016-2021)
Table 30. Global Voriconazole Vfend Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Voriconazole Vfend Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Voriconazole Vfend Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Voriconazole Vfend Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Voriconazole Vfend Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Voriconazole Vfend Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Voriconazole Vfend Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Voriconazole Vfend Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Voriconazole Vfend Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Voriconazole Vfend Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Voriconazole Vfend Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Voriconazole Vfend Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Voriconazole Vfend Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Voriconazole Vfend Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Voriconazole Vfend Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Voriconazole Vfend Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Voriconazole Vfend Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Voriconazole Vfend Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Voriconazole Vfend Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Voriconazole Vfend Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Voriconazole Vfend Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Voriconazole Vfend Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Voriconazole Vfend Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Voriconazole Vfend Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Voriconazole Vfend Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Voriconazole Vfend Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Voriconazole Vfend Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Voriconazole Vfend Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Voriconazole Vfend Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Voriconazole Vfend Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Voriconazole Vfend Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Voriconazole Vfend Market Size by Country (2022-2027) & (US$ Million)
Table 62. Pfizer Company Details
Table 63. Pfizer Business Overview
Table 64. Pfizer Voriconazole Vfend Product
Table 65. Pfizer Revenue in Voriconazole Vfend Business (2016-2021) & (US$ Million)
Table 66. Pfizer Recent Development
Table 67. Apotex Company Details
Table 68. Apotex Business Overview
Table 69. Apotex Voriconazole Vfend Product
Table 70. Apotex Revenue in Voriconazole Vfend Business (2016-2021) & (US$ Million)
Table 71. Apotex Recent Development
Table 72. Accord Healthcare Company Details
Table 73. Accord Healthcare Business Overview
Table 74. Accord Healthcare Voriconazole Vfend Product
Table 75. Accord Healthcare Revenue in Voriconazole Vfend Business (2016-2021) & (US$ Million)
Table 76. Accord Healthcare Recent Development
Table 77. Mylan Pharmaceuticals Company Details
Table 78. Mylan Pharmaceuticals Business Overview
Table 79. Mylan Pharmaceuticals Voriconazole Vfend Product
Table 80. Mylan Pharmaceuticals Revenue in Voriconazole Vfend Business (2016-2021) & (US$ Million)
Table 81. Mylan Pharmaceuticals Recent Development
Table 82. Pharmascience (Joddes) Company Details
Table 83. Pharmascience (Joddes) Business Overview
Table 84. Pharmascience (Joddes) Voriconazole Vfend Product
Table 85. Pharmascience (Joddes) Revenue in Voriconazole Vfend Business (2016-2021) & (US$ Million)
Table 86. Pharmascience (Joddes) Recent Development
Table 87. Auro Pharma Company Details
Table 88. Auro Pharma Business Overview
Table 89. Auro Pharma Voriconazole Vfend Product
Table 90. Auro Pharma Revenue in Voriconazole Vfend Business (2016-2021) & (US$ Million)
Table 91. Auro Pharma Recent Development
Table 92. Roche Company Details
Table 93. Roche Business Overview
Table 94. Roche Voriconazole Vfend Product
Table 95. Roche Revenue in Voriconazole Vfend Business (2016-2021) & (US$ Million)
Table 96. Roche Recent Development
Table 97. Macherey-Nagel GmbH Company Details
Table 98. Macherey-Nagel GmbH Business Overview
Table 99. Macherey-Nagel GmbH Revenue in Voriconazole Vfend Business (2016-2021) & (US$ Million)
Table 100. Macherey-Nagel GmbH Recent Development
Table 101. Jincheng HEALTH Pharmaceutical Company Details
Table 102. Jincheng HEALTH Pharmaceutical Business Overview
Table 103. Jincheng HEALTH Pharmaceutical Voriconazole Vfend Product
Table 104. Jincheng HEALTH Pharmaceutical Revenue in Voriconazole Vfend Business (2016-2021) & (US$ Million)
Table 105. Jincheng HEALTH Pharmaceutical Recent Development
Table 106. Takeda Company Details
Table 107. Takeda Business Overview
Table 108. Takeda Voriconazole Vfend Product
Table 109. Takeda Revenue in Voriconazole Vfend Business (2016-2021) & (US$ Million)
Table 110. Takeda Recent Development
Table 111. Novartis Company Details
Table 112. Novartis Business Overview
Table 113. Novartis Voriconazole Vfend Product
Table 114. Novartis Revenue in Voriconazole Vfend Business (2016-2021) & (US$ Million)
Table 115. Novartis Recent Development
Table 116. Aditya Pharma Company Details
Table 117. Aditya Pharma Business Overview
Table 118. Aditya Pharma Voriconazole Vfend Product
Table 119. Aditya Pharma Revenue in Voriconazole Vfend Business (2016-2021) & (US$ Million)
Table 120. Aditya Pharma Recent Development
Table 121. Daiichi Sankyo Company Details
Table 122. Daiichi Sankyo Business Overview
Table 123. Daiichi Sankyo Voriconazole Vfend Product
Table 124. Daiichi Sankyo Revenue in Voriconazole Vfend Business (2016-2021) & (US$ Million)
Table 125. Daiichi Sankyo Recent Development
Table 126. Taj Pharmaceuticals Company Details
Table 127. Taj Pharmaceuticals Business Overview
Table 128. Taj Pharmaceuticals Voriconazole Vfend Product
Table 129. Taj Pharmaceuticals Revenue in Voriconazole Vfend Business (2016-2021) & (US$ Million)
Table 130. Taj Pharmaceuticals Recent Development
Table 131. Sandoz Company Details
Table 132. Sandoz Business Overview
Table 133. Sandoz Voriconazole Vfend Product
Table 134. Sandoz Revenue in Voriconazole Vfend Business (2016-2021) & (US$ Million)
Table 135. Sandoz Recent Development
Table 136. Ebang Pharmaceutical Company Details
Table 137. Ebang Pharmaceutical Business Overview
Table 138. Ebang Pharmaceutical Voriconazole Vfend Product
Table 139. Ebang Pharmaceutical Revenue in Voriconazole Vfend Business (2016-2021) & (US$ Million)
Table 140. Ebang Pharmaceutical Recent Development
Table 141. GSK Company Details
Table 142. GSK Business Overview
Table 143. GSK Voriconazole Vfend Product
Table 144. GSK Revenue in Voriconazole Vfend Business (2016-2021) & (US$ Million)
Table 145. GSK Recent Development
Table 146. Teva Company Details
Table 147. Teva Business Overview
Table 148. Teva Voriconazole Vfend Product
Table 149. Teva Revenue in Voriconazole Vfend Business (2016-2021) & (US$ Million)
Table 150. Teva Recent Development
Table 151. Cilag AG Company Details
Table 152. Cilag AG Business Overview
Table 153. Cilag AG Voriconazole Vfend Product
Table 154. Cilag AG Revenue in Voriconazole Vfend Business (2016-2021) & (US$ Million)
Table 155. Cilag AG Recent Development
Table 156. Squibb Company Details
Table 157. Squibb Business Overview
Table 158. Squibb Voriconazole Vfend Product
Table 159. Squibb Revenue in Voriconazole Vfend Business (2016-2021) & (US$ Million)
Table 160. Squibb Recent Development
Table 161. Abbott Company Details
Table 162. Abbott Business Overview
Table 163. Abbott Voriconazole Vfend Product
Table 164. Abbott Revenue in Voriconazole Vfend Business (2016-2021) & (US$ Million)
Table 165. Abbott Recent Development
Table 166. Livzon Pharmaceutical Group Company Details
Table 167. Livzon Pharmaceutical Group Business Overview
Table 168. Livzon Pharmaceutical Group Voriconazole Vfend Product
Table 169. Livzon Pharmaceutical Group Revenue in Voriconazole Vfend Business (2016-2021) & (US$ Million)
Table 170. Livzon Pharmaceutical Group Recent Development
Table 171. Sichuan Beauty Sport Huakang Pharmaceutical Company Details
Table 172. Sichuan Beauty Sport Huakang Pharmaceutical Business Overview
Table 173. Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Vfend Product
Table 174. Sichuan Beauty Sport Huakang Pharmaceutical Revenue in Voriconazole Vfend Business (2016-2021) & (US$ Million)
Table 175. Sichuan Beauty Sport Huakang Pharmaceutical Recent Development
Table 176. Jincheng Haisi Pharmaceutical Company Details
Table 177. Jincheng Haisi Pharmaceutical Business Overview
Table 178. Jincheng Haisi Pharmaceutical Voriconazole VfendProduct
Table 179. Jincheng Haisi Pharmaceutical Revenue in Voriconazole Vfend Business (2016-2021) & (US$ Million)
Table 180. Jincheng Haisi Pharmaceutical Recent Development
Table 181. Zhuhai Yibang Pharmaceutical Company Details
Table 182. Zhuhai Yibang Pharmaceutical Business Overview
Table 183. Zhuhai Yibang Pharmaceutical Voriconazole Vfend Product
Table 184. Zhuhai Yibang Pharmaceutical Revenue in Voriconazole Vfend Business (2016-2021) & (US$ Million)
Table 185. Zhuhai Yibang Pharmaceutical Recent Development
Table 186. Beijing Bokang Gene Technology Company Details
Table 187. Beijing Bokang Gene Technology Business Overview
Table 188. Beijing Bokang Gene Technology Voriconazole Vfend Product
Table 189. Beijing Bokang Gene Technology Revenue in Voriconazole Vfend Business (2016-2021) & (US$ Million)
Table 190. Beijing Bokang Gene Technology Recent Development
Table 191. Chengdu Taihe Health Technology Group Company Details
Table 192. Chengdu Taihe Health Technology Group Business Overview
Table 193. Chengdu Taihe Health Technology Group Voriconazole Vfend Product
Table 194. Chengdu Taihe Health Technology Group Revenue in Voriconazole Vfend Business (2016-2021) & (US$ Million)
Table 195. Chengdu Taihe Health Technology Group Recent Development
Table 196. Yangtze Pharmaceutical Group Company Details
Table 197. Yangtze Pharmaceutical Group Business Overview
Table 198. Yangtze Pharmaceutical Group Voriconazole Vfend Product
Table 199. Yangtze Pharmaceutical Group Revenue in Voriconazole Vfend Business (2016-2021) & (US$ Million)
Table 200. Yangtze Pharmaceutical Group Recent Development
Table 201. Hubei Wushi Pharmaceutical Company Details
Table 202. Hubei Wushi Pharmaceutical Business Overview
Table 203. Hubei Wushi Pharmaceutical Voriconazole Vfend Product
Table 204. Hubei Wushi Pharmaceutical Revenue in Voriconazole Vfend Business (2016-2021) & (US$ Million)
Table 205. Hubei Wushi Pharmaceutical Recent Development
Table 206. Research Programs/Design for This Report
Table 207. Key Data Information from Secondary Sources
Table 208. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Voriconazole Vfend Market Share by Type: 2020 VS 2027
Figure 2. Injection Features
Figure 3. Tablets Features
Figure 4. Capsule Features
Figure 5. Global Voriconazole Vfend Market Share by Application: 2020 VS 2027
Figure 6. For People Case Studies
Figure 7. For Animal Case Studies
Figure 8. Voriconazole Vfend Report Years Considered
Figure 9. Global Voriconazole Vfend Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Voriconazole Vfend Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Voriconazole Vfend Market Share by Regions: 2020 VS 2027
Figure 12. Global Voriconazole Vfend Market Share by Regions (2022-2027)
Figure 13. Global Voriconazole Vfend Market Share by Players in 2020
Figure 14. Global Top Voriconazole Vfend Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Voriconazole Vfend as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Voriconazole Vfend Revenue in 2020
Figure 16. Global Voriconazole Vfend Revenue Market Share by Type (2016-2021)
Figure 17. Global Voriconazole Vfend Revenue Market Share by Type (2022-2027)
Figure 18. North America Voriconazole Vfend Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Voriconazole Vfend Market Share by Type (2016-2027)
Figure 20. North America Voriconazole Vfend Market Share by Application (2016-2027)
Figure 21. North America Voriconazole Vfend Market Share by Country (2016-2027)
Figure 22. United States Voriconazole Vfend Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Voriconazole Vfend Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Voriconazole Vfend Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Voriconazole Vfend Market Share by Type (2016-2027)
Figure 26. Europe Voriconazole Vfend Market Share by Application (2016-2027)
Figure 27. Europe Voriconazole Vfend Market Share by Country (2016-2027)
Figure 28. Germany Voriconazole Vfend Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Voriconazole Vfend Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Voriconazole Vfend Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Voriconazole Vfend Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Voriconazole Vfend Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Voriconazole Vfend Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Voriconazole Vfend Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Voriconazole Vfend Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Voriconazole Vfend Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Voriconazole Vfend Market Share by Region (2016-2027)
Figure 38. China Voriconazole Vfend Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Voriconazole Vfend Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Voriconazole Vfend Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Voriconazole Vfend Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Voriconazole Vfend Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Voriconazole Vfend Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Voriconazole Vfend Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Voriconazole Vfend Market Share by Type (2016-2027)
Figure 46. Latin America Voriconazole Vfend Market Share by Application (2016-2027)
Figure 47. Latin America Voriconazole Vfend Market Share by Country (2016-2027)
Figure 48. Mexico Voriconazole Vfend Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Voriconazole Vfend Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Voriconazole Vfend Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Voriconazole Vfend Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Voriconazole Vfend Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Voriconazole Vfend Market Share by Country (2016-2027)
Figure 54. Turkey Voriconazole Vfend Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Voriconazole Vfend Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Voriconazole Vfend Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Pfizer Revenue Growth Rate in Voriconazole Vfend Business (2016-2021)
Figure 58. Apotex Revenue Growth Rate in Voriconazole Vfend Business (2016-2021)
Figure 59. Accord Healthcare Revenue Growth Rate in Voriconazole Vfend Business (2016-2021)
Figure 60. Mylan Pharmaceuticals Revenue Growth Rate in Voriconazole Vfend Business (2016-2021)
Figure 61. Pharmascience (Joddes) Revenue Growth Rate in Voriconazole Vfend Business (2016-2021)
Figure 62. Auro Pharma Revenue Growth Rate in Voriconazole Vfend Business (2016-2021)
Figure 63. Roche Revenue Growth Rate in Voriconazole Vfend Business (2016-2021)
Figure 64. Macherey-Nagel GmbH Revenue Growth Rate in Voriconazole Vfend Business (2016-2021)
Figure 65. Jincheng HEALTH Pharmaceutical Revenue Growth Rate in Voriconazole Vfend Business (2016-2021)
Figure 66. Takeda Revenue Growth Rate in Voriconazole Vfend Business (2016-2021)
Figure 67. Novartis Revenue Growth Rate in Voriconazole Vfend Business (2016-2021)
Figure 68. Aditya Pharma Revenue Growth Rate in Voriconazole Vfend Business (2016-2021)
Figure 69. Daiichi Sankyo Revenue Growth Rate in Voriconazole Vfend Business (2016-2021)
Figure 70. Taj Pharmaceuticals Revenue Growth Rate in Voriconazole Vfend Business (2016-2021)
Figure 71. Sandoz Revenue Growth Rate in Voriconazole Vfend Business (2016-2021)
Figure 72. Ebang Pharmaceutical Revenue Growth Rate in Voriconazole Vfend Business (2016-2021)
Figure 73. GSK Revenue Growth Rate in Voriconazole Vfend Business (2016-2021)
Figure 74. Teva Revenue Growth Rate in Voriconazole Vfend Business (2016-2021)
Figure 75. Cilag AG Revenue Growth Rate in Voriconazole Vfend Business (2016-2021)
Figure 76. Squibb Revenue Growth Rate in Voriconazole Vfend Business (2016-2021)
Figure 77. Abbott Revenue Growth Rate in Voriconazole Vfend Business (2016-2021)
Figure 78. Livzon Pharmaceutical Group Revenue Growth Rate in Voriconazole Vfend Business (2016-2021)
Figure 79. Sichuan Beauty Sport Huakang Pharmaceutical Revenue Growth Rate in Voriconazole Vfend Business (2016-2021)
Figure 80. Jincheng Haisi Pharmaceutical Revenue Growth Rate in Voriconazole Vfend Business (2016-2021)
Figure 81. Zhuhai Yibang Pharmaceutical Revenue Growth Rate in Voriconazole Vfend Business (2016-2021)
Figure 82. Beijing Bokang Gene Technology Revenue Growth Rate in Voriconazole Vfend Business (2016-2021)
Figure 83. Chengdu Taihe Health Technology Group Revenue Growth Rate in Voriconazole Vfend Business (2016-2021)
Figure 84. Yangtze Pharmaceutical Group Revenue Growth Rate in Voriconazole Vfend Business (2016-2021)
Figure 85. Hubei Wushi Pharmaceutical Revenue Growth Rate in Voriconazole Vfend Business (2016-2021)
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed
世界のボリコナゾール（Vfend）市場規模・現状・予測（2021年-2027年） Voriconazole is a broad-spectrum antifungal agent for fungal infections in humans and animals. Market Analysis and Insights: Global Voriconazole Vfend Market The global Voriconazole Vfend market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2…- 世界のディスクロージングタブレット市場規模・現状・予測（2021年-2027年） Disclosing tablets are chewable tablets used to make dental plaque visible. The tablets contain a dye (typically a vegetable dye, such as Phloxine B) that stains plaque a bright color (typically red or blue). Market Analysis and Insights: Global Disclosing Tablets Market The global Disclosing Tablet…
- 世界の注射用ミカファンギンナトリウム市場規模・現状・予測（2021年-2027年） Micafungin (trade name Mycamine) is an echinocandin antifungal drug used to treat and prevent invasive fungal infections including candidemia, abscesses and esophageal candidiasis. It inhibits the production of beta-1,3-glucan, an essential component of fungal cell walls. Micafungin is administered …
- 世界の注射用ミカファンギンナトリウム市場規模・現状・予測（2021年-2027年） Micafungin (trade name Mycamine) is an echinocandin antifungal drug used to treat and prevent invasive fungal infections including candidemia, abscesses and esophageal candidiasis. It inhibits the production of beta-1,3-glucan, an essential component of fungal cell walls. Micafungin is administered …
- 世界のタブレット用ジェスチャ認識市場規模・現状・予測（2021年-2027年） Gesture recognition is the ability of a device to identify and respond to different gestures, such as movement of hands, fingers, arms, head, or the entire body, of an individual. In gesture recognition technology, a remotely-controlled device can be ideally operated using certain gestures, such as …